Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34+ cells

Bone Marrow Transplantation volume 32, pages 785–790 (2003)Cite this article

Summary:

Although autologous graft-versus-host disease (GVHD) can be induced by administration of cyclosporin A (CsA) after peripheral blood stem cell transplantation (PBSCT), the incidence appears to be remarkably lower compared to the incidence after bone marrow transplantation. The reduced incidence of autologous GVHD after PBSCT may be attributed to peripheral regulatory cells that are transferred with the stem cell inoculum. To determine whether transplantation of CD34-selected peripheral blood stem cells (PBSCs) leads to potentiation of autologous GVHD, five patients with malignant lymphoma were transplanted with CD34-selected PBSCs, followed by administration of CsA and interferon (IFN)-γ. Inducibility of autologous GVHD and autocytotoxic activities of peripheral blood mononuclear cells (PBMCs) after transplantation were assessed. All patients demonstrated prompt hematologic recovery. Cytotoxic activity of PBMCs against autologous lymphocytes was detectable in four of four patients analyzed during a limited period from days 14 to 34 post-transplant. An erythematous rash compatible with GVHD, confirmed by skin biopsy, developed in three of five patients. One of the three patients developed not only skin, but also gut and liver GVHD. Transplantation of the CD34-selected stem cell graft that does not accompany transfusion of regulatory cells may potentiate the inducibility of autologous GVHD by the administration of CsA and IFN-γ.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Glazier A, Tutschika PJ, Farmer ER, Santos GW . Graft-versus-host disease in cyclosporine treated rats after syngeneic autologous bone marrow reconstitution. J Exp Med 1983; 158: 1–8.

    Article  CAS  PubMed  Google Scholar 

  2. Hess AD, Horwitz L, Beschorner WE, Santos GW . Development of graft-vs-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. J Exp Med 1985; 161: 718–730.

    Article  CAS  PubMed  Google Scholar 

  3. Jones RJ, Vogelsang GB, Hess AD et al. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989; 333: 754–756.

    Article  Google Scholar 

  4. Fischer AC, Beschorner WE, Hess AD . Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease. J Exp Med 1989; 169: 1031–1041.

    Article  CAS  PubMed  Google Scholar 

  5. Vogelsang GB, Hess AD . Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061–2067.

    CAS  PubMed  Google Scholar 

  6. Miura Y, Thoburn CJ, Bright EC et al. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin-10 and interferon-gamma may be critical mediators for the development of autologous GVHD. Blood 2002; 100: 2650–2658.

    Article  CAS  PubMed  Google Scholar 

  7. Geller RB, Esa AH, Beschorner WE et al. Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat. Blood 1989; 74: 1165–1171.

    CAS  PubMed  Google Scholar 

  8. Hess AD, Bright EC, Thoburn CJ et al. Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide. Blood 1997; 89: 2203–2209.

    CAS  PubMed  Google Scholar 

  9. Hess AD, Thoburn CJ . Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease. Immunol Rev 1997; 157: 111–123.

    Article  CAS  PubMed  Google Scholar 

  10. Dolei A, Capobianchi MR, Ameglio F . Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immunol 1983; 40: 172–176.

    CAS  Google Scholar 

  11. Noga SJ, Horwitz L, Kim H et al. Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity. J Hematother 1992; 1: 75–84.

    Article  CAS  PubMed  Google Scholar 

  12. Yeager AM, Vogelsang GB, Jones RJ et al. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood 1992; 79: 3031–3035.

    CAS  PubMed  Google Scholar 

  13. Vogelsang G, Bitton R, Piantadosi S et al. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial. Bone Marrow Transplant 1999; 24: 637–640.

    Article  CAS  PubMed  Google Scholar 

  14. Marin GH, Porto A, Prates V et al. Graft versus host disease in autologous stem cell transplantation. J Exp Clin Cancer Res 1999; 18: 201–208.

    CAS  PubMed  Google Scholar 

  15. Miura Y, Ueda M, Zeng W et al. Induction of autologous graft-versus-host disease with cyclosporine A after peripheral blood stem cell transplantation: analysis of factors affecting induction. J Allergy Clin Immunol 2000; 106: 51–57.

    Article  Google Scholar 

  16. van der Wall E, Horn T, Bright E et al. Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells. Br J Cancer 2000; 83: 1405–1411.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pati AR, Godder KT, Abhyankar SH et al. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma. Bone Marrow Transplant 1996; 17: 1081–1083.

    CAS  PubMed  Google Scholar 

  18. Hess AD, Fischer AC, Horwitz L et al. Characterization of peripheral autoregulatory mechanisms that prevent development cyclosporine-induced syngeneic graft-versus-host disease. J Immunol 1994; 153: 400–411.

    CAS  PubMed  Google Scholar 

  19. Kappler JW, Roehm N, Marrack P . T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273–280.

    Article  CAS  PubMed  Google Scholar 

  20. Aguilar LK, Aguilar-Cordova E, Cartwright Jr J, Belmont JW . Thymic nurse cells are sites of thymocyte apoptosis. J Immunol 1994; 152: 2645–2651.

    CAS  PubMed  Google Scholar 

  21. Jenkins MK, Schwartz RH, Pardoll DM . Effects of cyclosporine A on T cell development and clonal deletion. Science 1988; 241: 1655–1658.

    Article  CAS  PubMed  Google Scholar 

  22. Gao EK, Lo D, Cheney R et al. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature 1988; 336: 176–179.

    Article  CAS  PubMed  Google Scholar 

  23. Hess AD, Fischer AC, Horwitz L et al. Characterization of peripheral autoregulatory mechanisms that prevent development cyclosporine-induced syngeneic graft-versus-host disease. J Immunol 1994; 53: 400–411.

    Google Scholar 

  24. Berenson RJ, Bensinger WI, Hill RS et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–1722.

    CAS  PubMed  Google Scholar 

  25. Gorin NC, Lopez M, Laporte JP et al. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 1995; 85: 1647–1654.

    CAS  PubMed  Google Scholar 

  26. Foucar K, McKenna RW, Frizzera G et al. Incidence and patterns of bone marrow and blood involvement by lymphoma in relationship to the Lukes–Collins classification. Blood 1979; 54: 1417–1422.

    CAS  PubMed  Google Scholar 

  27. McQuaker IG, Haynes AP, Anderson S et al. Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study. J Clin Oncol 1997; 15: 2288–2295.

    Article  CAS  PubMed  Google Scholar 

  28. Takahashi T, Kanda Y, Mori M et al. B cell lymphoma-associated hemophagocytic syndrome after PBSCT. Bone Marrow Transplant 1998; 21: 623–625.

    Article  CAS  PubMed  Google Scholar 

  29. Fischer AC, Hess AD . Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes. J Exp Med 1990; 172: 85–94.

    Article  CAS  PubMed  Google Scholar 

  30. Fischer AC, Laulis MK, Horwitz L et al. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets. J Immunol 1989; 143: 827–832.

    CAS  PubMed  Google Scholar 

  31. Wu DY, Goldschneider I . Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants. J Immunol 1999; 162: 6926–6933.

    CAS  PubMed  Google Scholar 

  32. Mielcarek M, Graf L, Johnson G, Torok-Storb B . Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 1998; 92: 215–222.

    CAS  PubMed  Google Scholar 

  33. Kusnierz-Glaz CR, Still BJ, Amano M et al. Granulocyte colony-stimulating factor induced comobilization of CD4−CD8− T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors. Blood 1997; 89: 2586–2595.

    CAS  PubMed  Google Scholar 

  34. Sica S, Chiusolo P, Salutari P et al. Autologous graft-versus-host disease after CD34+-purified autologous peripheral blood progenitor cell transplantation. J Hematother Stem Cell Res 2000; 9: 375–379.

    Article  CAS  PubMed  Google Scholar 

  35. Bastion Y, Brice P, Haioun C et al. Intensive therapy with peripheral-blood progenitor-cell transplantation in 60 patients with poor prognosis follicular lymphoma. Blood 1995; 86: 3257–3262.

    CAS  PubMed  Google Scholar 

  36. Schultze JL, Seamon MJ, Michalak S et al. Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro. Blood 1997; 89: 3806–3816.

    CAS  PubMed  Google Scholar 

  37. Dorfman DM, Schultze JL, Shahsafaei A et al. In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation. Blood 1997; 90: 4297–4306.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Christopher J Thoburn (Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center) for providing helpful discussion and critically reading the manuscript.

Author information

Authors and Affiliations

  1. The Sidney Kimmel Cancer Research Center at Johns Hopkins University, USA

    Y Miura & A D Hess

  2. Department of Internal Medicine, Kanazawa University Hospital, Japan

    Y Miura, A Takami, S Shiobara & S Nakao

  3. Department of Hematology and Immunology, Ishikawa Prefectural Central Hospital, Japan

    M Ueda

Authors
  1. Y Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Takami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Shiobara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Nakao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A D Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Miura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miura, Y., Ueda, M., Takami, A. et al. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34+ cells. Bone Marrow Transplant 32, 785–790 (2003). https://doi.org/10.1038/sj.bmt.1704208

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704208

Keywords

This article is cited by

Search

Advanced search

Quick links